• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Urothelial bladder biopsy--important evolution prognosis factor of superficial bladder cancer under intravesical Bacille Calmette-Guérin therapy.

作者信息

Geavlete P, Taşcă C

机构信息

University Department of Urology, Clinical Hospital Saint John, Bucharest, Romania.

出版信息

Rom J Morphol Embryol. 1991 Jan-Jun;37(1-2):61-8.

PMID:1801981
Abstract

During 11 years we investigated the value of multiple randomised biopsies (4 quadrant) and by in vivo staining with methylene blue (chromocystoscopy) of 231 cases with superficial bladder tumours under complementary intravesical Bacille Calmette-Guérin therapy (3 years of immunotherapic treatment after our protocol). We discovered the appearance of 20 cases with carcinoma insitu (Cis) and 105 cases with different degrees of dysplasia (simple, medium and severe). We demonstrated 69.44% pathological bladder biopsies on normal-looking mucosa. 75% of the recurrent tumours (44 cases-22.44%) had pathological bladder urothel al field modifications associated with bladder cancer. On this occasion, we point out the highest prognostic value of the complex protocol of superficial bladder tumour evaluation based on the study of the bladder biopsies as an essential parameter.

摘要

相似文献

1
Urothelial bladder biopsy--important evolution prognosis factor of superficial bladder cancer under intravesical Bacille Calmette-Guérin therapy.
Rom J Morphol Embryol. 1991 Jan-Jun;37(1-2):61-8.
2
Evolution of the urothelial bladder field after intravesical Bacille Calmette-Guérin therapy.
Acta Urol Belg. 1991;59(4):149-60.
3
Evolution of carcinoma in situ under intravesical Romanian Bacille Calmette-Guérin therapy.罗马尼亚卡介苗膀胱内灌注治疗下原位癌的演变
Rom J Morphol Embryol. 1991 Jan-Jun;37(1-2):69-74.
4
Discrepancies between cytology, cystoscopy and biopsy in bladder cancer detection after Bacille Calmette-Guerin intravesical therapy.卡介苗膀胱内灌注治疗后膀胱癌检测中细胞学、膀胱镜检查与活检结果的差异
Int J Urol. 2009 Feb;16(2):192-5. doi: 10.1111/j.1442-2042.2008.02200.x. Epub 2008 Nov 27.
5
Should bladder biopsies be performed routinely after bacillus Calmette-Guérin treatment for high-risk superficial transitional cell cancer of the bladder?
Eur Urol. 2006 Sep;50(3):516-20; discussion 520. doi: 10.1016/j.eururo.2006.03.022. Epub 2006 Mar 31.
6
Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value.卡介苗膀胱灌注治疗浅表性膀胱癌期间尿液细胞因子:处理、稳定性及预后价值
J Urol. 1996 Feb;155(2):477-82.
7
[Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].[卡介苗辅助膀胱内灌注治疗3级浅表性膀胱癌的结果]
Hinyokika Kiyo. 2004 Nov;50(11):767-71.
8
[Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining].[膀胱癌患者多次黏膜活检的研究。1. 膀胱癌患者多次黏膜活检结果及亚甲蓝活体染色评估]
Hinyokika Kiyo. 1986 Nov;32(11):1617-31.
9
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.卡介苗维持免疫疗法用于复发性TA、T1期及原位膀胱移行细胞癌:西南肿瘤协作组的一项随机研究
J Urol. 2000 Apr;163(4):1124-9.
10
Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin.尿白细胞介素-8和18可预测浅表性膀胱癌对卡介苗膀胱内灌注治疗的反应。
J Urol. 2000 Dec;164(6):2129-33.